Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy

BACKGROUND: Effectiveness of clinical therapy such as chemotherapy for solid tumors is limited by acquired drug resistance and side effects. Available antitumor immunity methods showed promising prospect of cancer therapy. However, more drug targets for boosting antitumor immunity still need to be e...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Changqing, Zhu, Xiaojue, Xu, Peiqi, Li, Yonghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339463/
https://www.ncbi.nlm.nih.gov/pubmed/30697058
http://dx.doi.org/10.2147/OTT.S182806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339463/
https://www.ncbi.nlm.nih.gov/pubmed/30697058
http://dx.doi.org/10.2147/OTT.S182806

Ejemplares similares